Intracellular activity of fosfomycin against two distinct enteropathogenic bacteria, Salmonella enterica and Listeria monocytogenes,alive inside host cells

Chemotherapy

Volumn 49, Issue 1-2, 2003, Pages 49-55

  Okada, Nobuhiko ^a   Nishio, Miki ^a   Danbara, Hirofumi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Antimicrobial activity; Fosfomycin; Intracellular bacteria

Indexed keywords

ANTIINFECTIVE AGENT; FOSFOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; CELL STRAIN CACO 2; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DRUG EFFICACY; EXTRACELLULAR SPACE; GROWTH INHIBITION; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; PHAGOSOME; PRIORITY JOURNAL; SALMONELLA ENTERICA;

ANTI-BACTERIAL AGENTS; CACO-2 CELLS; CYTOSOL; ENTEROCYTES; FOSFOMYCIN; HUMANS; INTRACELLULAR FLUID; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MICROBIAL SENSITIVITY TESTS; PHAGOSOMES; SALMONELLA ENTERICA; SALMONELLA INFECTIONS; TUMOR CELLS, CULTURED;

EID: 0037266135     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000069787     Document Type: Article

References (28)

1. Kumana CR, Yuen KY: Parenteral aminoglycoside therapy. Selection, administration and monitoring. Drugs 1994;47:902-913.
2. Christensen BG, Leanza WJ, Beattie TR, Patchett AA, Arison BH, Ormond RE, Kuehl FA Jr, Albers-Schonberg G, Jardetzky O: Phosphonomycin: Structure and synthesis. Science 1969;166:123-125.
3. Morikawa K, Oseko F, Morikawa S, Sawada M: Immunosuppressive activity of fosfomycin on human T-lymphocyte function in vitro. Antimicrob Agents Chemother 1993;37:2684-2687.
4. Morikawa K, Watabe H, Araake M, Morikawa S: Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob Agents Chemother 1996;40:1366-1370.
5. Wagner T, Kreft B, Bohlmann G, Schwieder G: Effects of fosfomycin, mesna, and sodium thio-sulfate on the toxicity and antitumor activity of cisplatin. J Cancer Res Clin Oncol 1988;114: 497-501.
6. Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y, Yamaguchi K: Immunomodulating effect of fosfomycin on gut-derived sepsis caused by Pseudomonas aeruginosa in mice. Antimicrob Agents Chemother 1997;41:308-313.
7. Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y, Yamaguchi K: Fosfomycin alters lipopolysaccharide-induced inflammatory cytokine production in mice. Antimicrob Agents Chemother 1999;43:697-698.
8. Kahan FM, Kahan JS, Cassidy PJ, Kropp H: The mechanism of action of fosfomycin (phosphonomycin). Ann NY Acad Sci 1974;235: 364-386.
9. Cozzarelli NR, Freedberg WB, Lin EC: Genetic control of L-alpha-glycerophosphate system in Escherichia coli. J Mol Biol 1968;31:371-387.
10. Tsuruoka T, Miyata A, Yamada Y: Two kinds of mutants defective in multiple carbohydrate utilization isolated from in vitro fosfomycin-resistant strains of Escherichia coli K-12. J Antibiot (Tokyo) 1978;31:192-201.
11. Jones RN, Barry AL, Gavan TL, Washington JA II: Susceptibility tests: Microdilution and macrodilution broth procedures; in Lennette EH, Balows A, Hausler WJ Jr, Shadomy HJ (eds): Manual of Clinical Microbiology, ed 4. Washington, American Society for Microbiology, 1985, pp 972-977.
12. Goto S: Fosfomycin, antimicrobial activity in vitro and in vivo. Chemotherapy 1977;23(suppl 1):63-74.
13. Krause R, Patruta S, Daxbock F, Fladerer P, Wenisch C: The effect of fosfomycin on neutrophil function. J Antimicrob Chemother 2001;47:141-146.
14. Trautmann M, Meincke C, Vogt K, Ruhnke M, Lajous-Petter AM: Intracellular bactericidal activity of fosfomycin against staphylococci: A comparison with other antibiotics. Infection 1992;20:350-354.
15. Ishizawa T, Hayashi M, Awazu S: Paracellular and transcellular permeabilities of fosfomycin across small intestinal membrane of rat and rabbit by voltage-clamp method. J Pharmacobiodyn 1991;14:583-589.
16. Ishizawa T, Hayashi M, Awazu S: Effect of carrier-mediated transport system on intestinal fosfomycin absorption in situ and in vivo. J Pharmacobiodyn 1991;14:82-86.
17. Ishizawa T, Sadahiro S, Hosoi K, Tamai I, Terasaki T, Tsuji A: Mechanisms of intestinal absorption of the antibiotic, fosfomycin, in brush-border membrane vesicles in rabbits and humans. J Pharmacobiodyn 1992;15:481-489.
18. Alper MD, Ames BN: Transport of antibiotics and metabolite analogs by systems under cyclic AMP control: Positive selection of Salmonella typhimurium cyaandcrpmutants. J Bacteriol 1978;133:149-157.
19. Kadner RJ, Winkler HH: Isolation and characterization of mutations affecting the transport of hexose phosphates in Escherichia coli. J Bacteriol 1973;113:895-900.
20. Cordaro JC, Melton T, Stratis JP, Atagun M, Gladding C, Hartman PE, Roseman S: Fosfomycin resistance: Selection method for internal and extended deletions of the phosphoenolpyruvate:sugar phosphotransferase genes of Salmonella typhimurium. J Bacteriol 1976;128:785-793.
21. Tsuruoka T, Yamada Y: Characterization of spontaneous fosfomycin (phosphonomycin)-resistant cells of Escherichia coli B in vitro. J Antibiot (Tokyo) 1975;28:906-911.
22. Marquardt JL, Siegele DA, Kolter R, Walsh CT: Cloning and sequencing of Escherichia coli murZ and purification of its product, a UDP-N-acetylglucosamine enolpyruvyl transferase. J Bacteriol 1992;174:5748-5752.
23. Venkateswaran PS, Wu HC: Isolation and characterization of a phosphonomycin-resistant mutant of Escherichia coli K-12. J Bacteriol 1972;110:935-944.
24. Arca P, Reguera G, Hardisson C: Plasmid-encoded fosfomycin resistance in bacteria isolated from the urinary tract in a multicentre survey. J Antimicrob Chemother 1997;40:393-399.
25. Etienne J, Gerbaud G, Courvalin P, Fleurette J: Plasmid-mediated resistance to fosfomycin in Staphylococcus epidermidis. FEMS Microbiol Lett 1989;52:133-137.
26. Mendoza C, Garcia JM, Llaneza J, Mendez FJ, Hardisson C, Ortiz JM: Plasmid-determined resistance to fosfomycin in Serratia marcescens. Antimicrob Agents Chemother 1980;18: 215-219.
27. O'Hara K: Two different types of fosfomycin resistance in clinical isolates ofKlebsiella pneumoniae. FEMS Microbiol Lett 1993;114:9-16.
28. Suarez JE, Mendoza MC: Plasmid-encoded fosfomycin resistance. Antimicrob Agents Chemother 1991;35:791-795.